Literature DB >> 19318139

Otosclerosis: an autoimmune disease?

Tamás Karosi1, Zoltán Szekanecz, István Sziklai.   

Abstract

OBJECTIVES: To review our current knowledge of the etiopathogenesis of otosclerotic bone remodeling including genetics, viral infection, autoimmunity and inflammation and to discuss disease pathogenesis with relevance for pharmacotherapy. SYSTEMATIC REVIEW
METHODOLOGY: Relevant publications on the etiopathogenesis, molecular biology, genetics and histopathology of otosclerosis from 1984 to 2009 were analyzed. RESULTS AND
CONCLUSIONS: Otosclerosis is a bone remodeling disorder of the human otic capsule, however, the etiopathogenesis remains unclear. Genetic predisposition, disturbed bone metabolism, persistent measles virus infection, autoimmunity, hormonal and environmental factors also may play contributing roles in the pathogenesis of otosclerosis. Since, diagnosis of otosclerosis is still based on histopathological examination of the removed stapes footplate, systemic prospective studies based on comprehensive histopathological and molecular biological analysis are necessary to get further information about the background of disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19318139     DOI: 10.1016/j.autrev.2009.03.009

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  11 in total

1.  Controversies in RELN/reelin expression in otosclerosis.

Authors:  Péter Csomor; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-06-01       Impact factor: 2.503

2.  Does otosclerosis affect the dimensions of the facial canal and cochlear aquaduct?

Authors:  Vefa Cakmak; Pinar Cakmak
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-06       Impact factor: 2.503

3.  Stapedotomy and its effect on hearing - our experience with 54 cases.

Authors:  Taiwo Olugbemiga Adedeji; Shabbir Indorewala; Abuzar Indorewala; Gaurav Nemade
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

4.  Advantages of multiplex proteomics in clinical immunology: the case of rheumatoid arthritis: novel IgXPLEX™: planar microarray diagnosis.

Authors:  Peter Lea; Edward Keystone; Sasi Mudumba; Anthony Kahama; Shi-Fa Ding; Jennifer Hansen; Azar A Azad; Sihe Wang; Deborah Weber
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

5.  No evidence for disturbed COL1A1 and A2 expression in otosclerosis.

Authors:  Péter Csomor; Balázs Liktor; Bálint Liktor; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-01       Impact factor: 2.503

6.  Restriction analysis of otosclerosis-associated CD46 splicing variants.

Authors:  Péter Csomor; Anita Szalmás; József Kónya; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-14       Impact factor: 2.503

Review 7.  Perspectives of pharmacological treatment in otosclerosis.

Authors:  Balázs Liktor; Zoltán Szekanecz; Tamás József Batta; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-29       Impact factor: 2.503

8.  Long-term hearing results of stapedotomy: analysis of factors affecting outcome.

Authors:  Ingeborg Dhooge; Stéphanie Desmedt; Thomas Maly; David Loose; Helen Van Hoecke
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-02-16       Impact factor: 2.503

9.  Otosclerosis Associated with a De Novo Mutation -832G > A in the TGFB1 Gene Promoter Causing a Decreased Expression Level.

Authors:  Saurabh Priyadarshi; Kirtal Hansdah; Chinmay Sundar Ray; Narayan Chandra Biswal; Puppala Venkat Ramchander
Journal:  Sci Rep       Date:  2016-07-11       Impact factor: 4.379

10.  Detection of otosclerosis-specific measles virus receptor (cd46) protein isoforms.

Authors:  Balázs Liktor; Péter Csomor; Tamás Karosi
Journal:  ISRN Otolaryngol       Date:  2013-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.